Chugai Pharmaceutical Forecast, price target & analysts
Chugai Pharmaceutical Target price 2024 - Analyst rating & recommendation
Chugai Pharmaceutical Classifications & Recommendation:
Chugai Pharmaceutical Price Target
| Target Price | JPY7,435.00 |
| Price | JPY6,375.00 |
| Potential |
16.63%
register free of charge
|
| Number of Estimates | 10 |
|
10 Analysts have issued a price target Chugai Pharmaceutical 2025 .
The average Chugai Pharmaceutical target price is JPY7,435.00.
This is
16.63%
register free of charge
JPY9,900.00
55.29%
register free of charge
JPY4,500.00
29.41%
register free of charge
|
|
| A rating was issued by 12 analysts: 5 Analysts recommend Chugai Pharmaceutical to buy, 6 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Chugai Pharmaceutical stock has an average upside potential 2025 of
16.63%
register free of charge
|
Sales and Margin forecast 2024, 2025 to 2028
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Revenue Billion JPY | 1,111.37 | 1,142.82 |
| 11.79% | 2.83% | |
| EBITDA Margin | 40.26% | 48.78% |
| 10.29% | 21.17% | |
| Net Margin | 29.29% | 33.26% |
| 1.48% | 13.55% |
10 Analysts have issued a sales forecast Chugai Pharmaceutical 2024 . The average Chugai Pharmaceutical sales estimate is
This results in the following potential growth metrics:
7 Analysts have issued an Chugai Pharmaceutical EBITDA forecast 2024. The average Chugai Pharmaceutical EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
5 Chugai Pharmaceutical Analysts have issued a net profit forecast 2024. The average Chugai Pharmaceutical net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Earnings Per Share JPY | 197.83 | 230.97 |
| 13.10% | 16.75% | |
| P/E | 28.13 | |
| EV/Sales | 8.62 |
5 Analysts have issued a Chugai Pharmaceutical forecast for earnings per share. The average Chugai Pharmaceutical <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Chugai Pharmaceutical stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Chugai Pharmaceutical...
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
